{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:54:43Z","timestamp":1787136883564,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471000"],"award-info":[{"award-number":["32471000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08704-6","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T13:05:50Z","timestamp":1756127150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Single-dose infusion of engineered viral receptor binding domain confers rapid and durable protection against viral infection"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2573-9842","authenticated-orcid":false,"given":"Haiqiao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6863-6019","authenticated-orcid":false,"given":"Bei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haokun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunyu","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixia","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanri","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwen","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9973-8130","authenticated-orcid":false,"given":"Kai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianchi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-3953","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"8704_CR1","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1093\/cid\/civ069","volume":"60","author":"C Irvine","year":"2015","unstructured":"Irvine, C. et al. Efficacy of HIV Postexposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate Studies. Clin. Infect. Dis. 60, S165\u2013S169 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"8704_CR2","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1093\/cid\/civ092","volume":"60","author":"N Ford","year":"2015","unstructured":"Ford, N. et al. Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review. Clin. Infect. Dis. 60, S170\u2013S176 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"8704_CR3","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/infdis\/jiw223","volume":"214","author":"SM Jenness","year":"2016","unstructured":"Jenness, S. M. et al. Impact of the Centers for Disease Control\u2019s HIV Preexposure Prophylaxis Guidelines for men who have sex with men in the United States. J. Infect. Dis. 214, 1800\u20131807 (2016).","journal-title":"J. Infect. Dis."},{"key":"8704_CR4","doi-asserted-by":"publisher","first-page":"ofx061","DOI":"10.1093\/ofid\/ofx061","volume":"4","author":"MR Beymer","year":"2017","unstructured":"Beymer, M. R. et al. Differentiating nonoccupational postexposure prophylaxis seroconverters and non-seroconverters in a community-based clinic in Los Angeles, California. Open Forum Infect. Dis. 4, ofx061 (2017).","journal-title":"Open Forum Infect. Dis."},{"key":"8704_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/QAD.0000000000003494","volume":"37","author":"VA Fonner","year":"2023","unstructured":"Fonner, V. A. et al. Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition. AIDS 37, 957\u2013966 (2023).","journal-title":"AIDS"},{"key":"8704_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/S0140-6736(99)05005-9","volume":"355","author":"JM Parkin","year":"2000","unstructured":"Parkin, J. M. et al. Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet 355, 722\u2013723 (2000).","journal-title":"Lancet"},{"key":"8704_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/sti.2005.017764","volume":"82","author":"S Day","year":"2006","unstructured":"Day, S., Mears, A., Bond, K. & Kulasegaram, R. Post-exposure HIV prophylaxis following sexual exposure: a retrospective audit against recent draft BASHH guidance. Sex. Transm. Infect. 82, 236\u2013237 (2006).","journal-title":"Sex. Transm. Infect."},{"key":"8704_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/OLQ.0b013e3181b6f284","volume":"37","author":"S Lunding","year":"2010","unstructured":"Lunding, S. et al. The Danish PEP Registry: Experience With the Use of Postexposure Prophylaxis (PEP) Following Sexual Exposure to HIV From 1998 to 2006. Sex. Transmit. Dis. 37, 49\u201352 (2010).","journal-title":"Sex. Transmit. Dis."},{"key":"8704_CR9","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/cid\/civ511","volume":"61","author":"R Foster","year":"2015","unstructured":"Foster, R. et al. Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in men who have sex with men. Clin. Infect. Dis. 61, 1336\u20131341 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"8704_CR10","doi-asserted-by":"publisher","unstructured":"Valin, N. et al. Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis. BMC Infect. Dis. 16, https:\/\/doi.org\/10.1186\/s12879-016-2056-3 (2016).","DOI":"10.1186\/s12879-016-2056-3"},{"key":"8704_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/978-94-007-6552-8_15","volume":"68","author":"JM Casasnovas","year":"2013","unstructured":"Casasnovas, J. M. Virus-receptor interactions and receptor-mediated virus entry into host cells. Subcell. Biochem 68, 441\u2013466 (2013).","journal-title":"Subcell. Biochem"},{"key":"8704_CR12","doi-asserted-by":"publisher","first-page":"9254","DOI":"10.1073\/pnas.83.23.9254","volume":"83","author":"CB Pert","year":"1986","unstructured":"Pert, C. B. et al. Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc. Natl. Acad. Sci. USA 83, 9254\u20139258 (1986).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8704_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.antiviral.2005.03.007","volume":"67","author":"MT Polianova","year":"2005","unstructured":"Polianova, M. T., Ruscetti, F. W., Pert, C. B. & Ruff, M. R. Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA). Antivir. Res. 67, 83\u201392 (2005).","journal-title":"Antivir. Res."},{"key":"8704_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/vaccines2030515","volume":"2","author":"W Li","year":"2014","unstructured":"Li, W., Joshi, M., Singhania, S., Ramsey, K. & Murthy, A. Peptide vaccine: progress and challenges. Vaccines 2, 515\u2013536 (2014).","journal-title":"Vaccines"},{"key":"8704_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221\u2013224 (2020).","journal-title":"Nature"},{"key":"8704_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181, 281\u2013292 e286 (2020).","journal-title":"Cell"},{"key":"8704_CR17","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1016\/j.cell.2021.07.025","volume":"184","author":"P Tong","year":"2021","unstructured":"Tong, P. et al. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike. Cell 184, 4969\u20134980 e4915 (2021).","journal-title":"Cell"},{"key":"8704_CR18","doi-asserted-by":"publisher","unstructured":"Premkumar, L. et al. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci. Immunol. 5, https:\/\/doi.org\/10.1126\/sciimmunol.abc8413 (2020).","DOI":"10.1126\/sciimmunol.abc8413"},{"key":"8704_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cell.2022.11.030","volume":"186","author":"CT Wu","year":"2023","unstructured":"Wu, C. T. et al. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming. Cell 186, 112\u2013130 e120 (2023).","journal-title":"Cell"},{"key":"8704_CR20","doi-asserted-by":"publisher","first-page":"eabj5129","DOI":"10.1126\/sciimmunol.abj5129","volume":"6","author":"JE Oh","year":"2021","unstructured":"Oh, J. E. et al. Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA. Sci. Immunol. 6, eabj5129 (2021).","journal-title":"Sci. Immunol."},{"key":"8704_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo2523","author":"T Mao","year":"2022","unstructured":"Mao, T. et al. Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses. Science 378, eabo2523 (2022).","journal-title":"Science"},{"key":"8704_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0958-1669(02)00352-X","volume":"13","author":"SK Batra","year":"2002","unstructured":"Batra, S. K., Jain, M., Wittel, U. A., Chauhan, S. C. & Colcher, D. Pharmacokinetics and biodistribution of genetically engineered antibodies. Curr. Opin. Biotechnol. 13, 603\u2013608 (2002).","journal-title":"Curr. Opin. Biotechnol."},{"key":"8704_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nbt.1742","volume":"29","author":"L Ye","year":"2011","unstructured":"Ye, L., Zeng, R., Bai, Y., Roopenian, D. C. & Zhu, X. Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat. Biotechnol. 29, 158\u2013163 (2011).","journal-title":"Nat. Biotechnol."},{"key":"8704_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42796-0","volume":"14","author":"W Li","year":"2023","unstructured":"Li, W. et al. An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission. Nat. Commun. 14, 7114 (2023).","journal-title":"Nat. Commun."},{"key":"8704_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.20020400","volume":"196","author":"GM Spiekermann","year":"2002","unstructured":"Spiekermann, G. M. et al. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J. Exp. Med. 196, 303\u2013310 (2002).","journal-title":"J. Exp. Med."},{"key":"8704_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Yang, C., Xu, X. F., Xu, W. & Liu, S. W. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharm. Sin. 41, 1141\u20131149 (2020).","journal-title":"Acta Pharm. Sin."},{"key":"8704_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26401-w","volume":"12","author":"P Han","year":"2021","unstructured":"Han, P. et al. Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants. Nat. Commun. 12, 6103 (2021).","journal-title":"Nat. Commun."},{"key":"8704_CR28","doi-asserted-by":"publisher","first-page":"e2100422","DOI":"10.1002\/biot.202100422","volume":"17","author":"M Klausberger","year":"2022","unstructured":"Klausberger, M. et al. Designed SARS-CoV-2 receptor binding domain variants form stable monomers. Biotechnol. J. 17, e2100422 (2022).","journal-title":"Biotechnol. J."},{"key":"8704_CR29","doi-asserted-by":"publisher","unstructured":"Crawford, K. H. D. et al. Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays. Viruses 12, https:\/\/doi.org\/10.3390\/v12050513 (2020).","DOI":"10.3390\/v12050513"},{"key":"8704_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"8704_CR31","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","volume":"21","author":"ES Winkler","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327\u20131335 (2020).","journal-title":"Nat. Immunol."},{"key":"8704_CR32","doi-asserted-by":"publisher","first-page":"e0273430","DOI":"10.1371\/journal.pone.0273430","volume":"17","author":"KS Lee","year":"2022","unstructured":"Lee, K. S. et al. SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice. PLoS One 17, e0273430 (2022).","journal-title":"PLoS One"},{"key":"8704_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ni.1838","volume":"11","author":"A Ballesteros-Tato","year":"2010","unstructured":"Ballesteros-Tato, A., Leon, B., Lund, F. E. & Randall, T. D. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat. Immunol. 11, 216\u2013224 (2010).","journal-title":"Nat. Immunol."},{"key":"8704_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.193.1.51","volume":"193","author":"KY Vermaelen","year":"2001","unstructured":"Vermaelen, K. Y., Carro-Muino, I., Lambrecht, B. N. & Pauwels, R. A. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med 193, 51\u201360 (2001).","journal-title":"J. Exp. Med"},{"key":"8704_CR35","doi-asserted-by":"publisher","unstructured":"Bedford, J. G. et al. Unresponsiveness to inhaled antigen is governed by conventional dendritic cells and overridden during infection by monocytes. Sci. Immunol. 5, https:\/\/doi.org\/10.1126\/sciimmunol.abb5439 (2020).","DOI":"10.1126\/sciimmunol.abb5439"},{"key":"8704_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","volume":"22","author":"EC Lavelle","year":"2022","unstructured":"Lavelle, E. C. & Ward, R. W. Mucosal vaccines - fortifying the frontiers. Nat. Rev. Immunol. 22, 236\u2013250 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"8704_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41392-022-01002-1","volume":"7","author":"H Lei","year":"2022","unstructured":"Lei, H. et al. Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants. Signal Transduct. Target Ther. 7, 159 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"8704_CR38","doi-asserted-by":"publisher","unstructured":"Kawai, A. et al. Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses. J. Clin. Invest. 133, https:\/\/doi.org\/10.1172\/JCI166827 (2023).","DOI":"10.1172\/JCI166827"},{"key":"8704_CR39","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.4049\/jimmunol.2100297","volume":"207","author":"SP Ochsner","year":"2021","unstructured":"Ochsner, S. P. et al. FcRn-targeted mucosal vaccination against influenza virus infection. J. Immunol. 207, 1310\u20131321 (2021).","journal-title":"J. Immunol."},{"key":"8704_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nprot.2014.005","volume":"9","author":"KG Anderson","year":"2014","unstructured":"Anderson, K. G. et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209\u2013222 (2014).","journal-title":"Nat. Protoc."},{"key":"8704_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41590-018-0260-6","volume":"20","author":"SR Allie","year":"2019","unstructured":"Allie, S. R. et al. The establishment of resident memory B cells in the lung requires local antigen encounter. Nat. Immunol. 20, 97\u2013108 (2019).","journal-title":"Nat. Immunol."},{"key":"8704_CR42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","volume":"22","author":"G Li","year":"2023","unstructured":"Li, G., Hilgenfeld, R., Whitley, R. & De Clercq, E. Therapeutic strategies for COVID-19: progress and lessons learned. Nat. Rev. Drug Discov. 22, 449\u2013475 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8704_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01636-4","volume":"18","author":"A Torneri","year":"2020","unstructured":"Torneri, A. et al. A prospect on the use of antiviral drugs to control local outbreaks of COVID-19. BMC Med. 18, 191 (2020).","journal-title":"BMC Med."},{"key":"8704_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s43440-023-00463-7","volume":"75","author":"VP Chavda","year":"2023","unstructured":"Chavda, V. P., Baviskar, K. P., Vaghela, D. A., Raut, S. S. & Bedse, A. P. Nasal sprays for treating COVID-19: a scientific note. Pharm. Rep. 75, 249\u2013265 (2023).","journal-title":"Pharm. Rep."},{"key":"8704_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41392-021-00740-y","volume":"6","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduct. Target Ther. 6, 315 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"8704_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25331-x","volume":"12","author":"Y Du","year":"2021","unstructured":"Du, Y. et al. A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants. Nat. Commun. 12, 5000 (2021).","journal-title":"Nat. Commun."},{"key":"8704_CR47","doi-asserted-by":"crossref","unstructured":"Tang, J. et al. Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination. Sci Immunol, eadd4853 (2022).","DOI":"10.3410\/f.742242065.793594287"},{"key":"8704_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","volume":"15","author":"S Sheikh-Mohamed","year":"2022","unstructured":"Sheikh-Mohamed, S. et al. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Mucosal Immunol. 15, 799\u2013808 (2022).","journal-title":"Mucosal Immunol."},{"key":"8704_CR49","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.immuni.2022.03.003","volume":"55","author":"AJ MacLean","year":"2022","unstructured":"MacLean, A. J. et al. Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites. Immunity 55, 718\u2013733. e718 (2022).","journal-title":"Immunity"},{"key":"8704_CR50","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.cell.2018.09.042","volume":"175","author":"Y Yao","year":"2018","unstructured":"Yao, Y. et al. Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity. Cell 175, 1634\u20131650 e1617 (2018).","journal-title":"Cell"},{"key":"8704_CR51","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2012.11.020","volume":"38","author":"D Baumjohann","year":"2013","unstructured":"Baumjohann, D. et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 38, 596\u2013605 (2013).","journal-title":"Immunity"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08704-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:11:35Z","timestamp":1757434295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08704-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8704"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08704-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1279"}}